Related Experiment Videos
[Slow development of multiorgan tuberculosis in an infant]
I Kacprzak-Bergman1, J Remion, I Zaleska
1Katedra i Klinika Chorób Zakaźnych Dzieci Akademii Medycznej we Wrocławiu.
Pediatria Polska
|January 1, 1995
Summary
BCG vaccination did not prevent severe tuberculosis, including miliary tuberculosis and meningoencephalitis, in an infant. Early diagnosis and 9 months of anti-tuberculosis therapy led to a successful outcome.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) remains a global health challenge.
- BCG vaccination is a primary tool for preventing severe childhood TB.
- Infants, especially those with prolonged symptoms, require careful diagnostic evaluation.
Observation:
- A 2-month-old infant, vaccinated with BCG, presented with cervico-lymphadenitis.
- Initial non-specific treatment for 8 months delayed the diagnosis of tuberculosis.
- The infant later developed severe disseminated forms: miliary tuberculosis and meningoencephalitis.
Findings:
- Despite BCG vaccination, disseminated tuberculosis occurred.
- Familial tuberculosis contact was identified as a potential source of infection.
- Prompt anti-tuberculosis therapy over 9 months resulted in a favorable clinical outcome.
Implications:
- BCG vaccination may not offer complete protection against all forms of tuberculosis.
- Delayed diagnosis in infants can lead to severe, life-threatening disease.
- Early recognition and comprehensive anti-TB treatment are crucial for favorable outcomes in infants.